Anavex Life Sciences Corp., of Geneva, appointed Hervé de Kergrohen CEO and director...Cadence Pharmaceuticals Inc., of San Diego, named Scott Byrd senior vice president and chief commercial officer

Cadence Pharmaceuticals Inc., of San Diego, named Scott Byrd senior vice president and chief commercial officer...ISTA Pharmaceuticals, of Irvine, Calif., appointed Brian G. Drazbav vice president of finance and chief accounting officer and Glenn E. Davis vice president of legal and chief compliance officer

It also named Mark Senner president and director, Christopher Hopton chief financial officer and John Dougherty to corporate development...Transgenomic Inc., of Omaha, Neb., appointed Antonius P. Schuh and Michael B. McNulty to its board

Ipsen Group, of Paris, named Jean-Christophe Tellier president and general manager of the firm's North American operations...Leerink Swann, of Boston, named Brent Clough senior managing director and head of MEDACorp...MDRNA Inc., of Bothell, Wash., appointed Beverly L. Davidson and Carl Novina to its scientific advisory board

It also promoted Jeff Devlin to chief operating officer and Peter Collins to senior vice president of business development...Endo Pharmaceuticals, of Chadds Ford, Pa., appointed Alan G. Levin executive vice president and chief financial officer...FoldRx Pharmaceuticals Inc., of Cambridge, Mass., named William E. Aliski senior vice president and chief commercial officer

Ablynx, of Ghent, Belgium, named Christian Duby medical director and Sean A. MacDonald business development director...Bioheart Inc., of Sunrise, Fla., named Mark Borman and Charles Hart to its board...Bionovo Inc., of Emeryville, Calif., appointed Klaus Kohl senior vice president and chief technical officer

Shire plc, of Basingstoke, UK, appointed Anne Wilms senior vice president and chief information officer...Spartan Bioscience Inc., of Ottawa, Ontario, promoted Mark D. Kershey to president and named Jay Rau director of business development and Susie Kagel director of U.S

OctoPlus NV, of Leiden, the Netherlands, appointed James Gale to its board and reappointed Philip Smith...Pharmalink AB, of Stockholm, Sweden, added Anders Wiklund, Jens Christensen and Lennart Hansson to its board...Proteolix Inc., of South San Francisco, added Craig Parker as senior vice president of finance and corporate development and chief financial officer, Michael Kauffman as chief medical officer and Albert Krausas vice president of regulatory affairs and quality assurance

Robert Belshe, director of infectious diseases and immunology at the St. Louis University School of Medicine...and Richard Whitley, co-director of the University of Alabama at Birmingham Center for Emerging Infections and Emergency Preparedness

subsidiary, which raises awareness of subclinical zinc deficiency and chronic copper toxicity...BiOasis Technologies Inc., of Vancouver, British Columbia, appointed Michael Edward Shannon senior medical advisor and as a board member...Cangene Corp., of Toronto, hired Paul Brisebois as vice president of sales, marketing and business development

Sygnature Chemical Services Ltd., of Nottingham, UK, appointed Paul Clewlow senior vice president of business development, and an executive member of the board

N30 Pharma, of Boulder, Colo., made these appointments to its scientific advisory board: Chairman Joseph Loscalzo, Augustine Choi, Michael Marletta, William Sessa and Joseph Vita...Sigma-Aldrich, of St. Louis, appointed Michael Kanan vice president and corporate controller

Infinity Pharmaceuticals Inc., of Cambridge, Mass., promoted John J. Keilty to vice president of information technology and informatics, and Joseph F. McPherson to vice president of facilities and operations...Microbia, Inc., of Lexington, Mass., appointed Mike Doyle senior vice president and general manager of nutrition ingredients...promoted Stephen DiPalma to executive vice president of business operations and chief financial officer

AVI BioPharma Inc., of Portland, Ore., appointed Christopher S. Henney and M. Kathleen Behrens to its board...Richmond, Calif., appointed Joseph T. Kennedy vice president, general counsel and secretary...Dafna Cohen and Yaron Diament were appointed external directors

Bioheart Inc., of Sunrise, Fla., named Michael Brown and Judy Brown research consultants...PDL BioPharma Inc., of Incline Village, Nev., elected Frederick Frank and Jody Lindell to its board...Savara Inc., of Austin, Texas, elected Nevan Elam, Curt Bilby and Matthew Dennis to its board

Sinobiomed Inc., of Shanghai, China, made these appointments: Anchie Kuo, president and CEO...Brent Suen, head of strategic development and mergers and acquisitions

AVI BioPharma Inc., of Portland, Ore., appointed Stephen B. Shrewsbury chief medical officer and senior vice president of clinical and regulatory affairs Biota Holdings Ltd., of Melbourne, Australia, appointed James Fox as a nonexecutive director and chairman...WuXi PharmaTech, of Shanghai, China, added Stewart Hen and Ning Zhao to its board...XTL Biopharmaceuticals Ltd., of Valley Cottage, N.Y., appointed David Grossman and Boaz Shweiger to its board

Aerovance Inc., of Berkeley, Calif., appointed Babatunde A. Otulana senior vice president and chief medical officer...F2G Ltd., of Manchester, UK, appointed Tony Kennedy chief scientific and development officer...Gentel Biosciences, of Madison, Wis., promoted G. Randall Durnell to executive vice president and chief operating officer

Pluristem Therapeutics Inc., of New York, appointed Frida Grynspan vice president of research and development...PDL BioPharma Inc., of Incline Village, Nev., appointed Christopher L. Stone vice president, general counsel and secretary